A Phase 3 Study of Efepoetin Alfa for Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis

NCT06466785 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

429

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia of Chronic Kidney Disease

Interventions

DRUG: Efepoetin Alfa
DRUG: Darbepoetin Alfa

Sponsor

Genexine, Inc.

Collaborators

[object Object]